Nancy Wysenski

Nancy Wysenski has an estimated net worth of $37 Million. This is based on reported shares across multiple companies, which include VERTEX PHARMACEUTICALS INC / MA, TETRAPHASE PHARMACEUTICALS INC, Provention Bio, Inc., INOVIO PHARMACEUTICALS, INC., CYTOKINETICS INC, Alkermes plc., Dova Pharmaceuticals Inc., ENDO PHARMACEUTICALS HOLDINGS INC, NORTH AMERICAN SCIENTIFIC INC, and INDEVUS PHARMACEUTICALS INC.

2012 was Nancy Wysenski's most active year for acquiring shares with 13 total transactions. Nancy Wysenski's most active month to acquire stocks was the month of April. 2012 was Nancy Wysenski's most active year for disposing of shares, totalling 20 transactions. Nancy Wysenski's most active month to dispose stocks was the month of April. 2012 saw Nancy Wysenski paying a total of $14,203,207.17 for 447,705 shares, this is the most they've acquired in one year. In 2012 Nancy Wysenski cashed out on 912,450 shares for a total of $33,771,081.27, their largest year based on trade value.